Advertisement
Screener

ELOXX PHARMACEUTICALS, INC. (ELOX) ROI

ELOXX PHARMACEUTICALS, INC. (ELOX) ROI

  • 2023-12-31: ROI 90.87%.
  • 2023-09-30: ROI 140.21%.
  • 2023-06-30: ROI 187.88%.
  • 2023-03-31: ROI -140.35%.

Complete source-backed roi history.

Available history
2019-03-31 to 2025-12-31
Data captured

Historical ROI

DateROI
2023-12-3190.87%
2023-09-30140.21%
2023-06-30187.88%
2023-03-31-140.35%
2022-12-31-1921.42%
2022-09-30-564.51%
2022-06-30-314.33%
2021-12-31-194.09%
2021-06-30-115.07%
2021-03-31-221.74%
2020-12-31-158.28%
2020-09-30-144.09%
2020-06-30-135.72%
2020-03-31-130.90%
2019-12-31-99.65%
2019-09-30-88.91%
2019-06-30-73.90%
2019-03-31-103.45%

Annual ROI

DateROI
2025-12-3154.96%
2024-12-3117.64%
2023-12-3190.87%
2022-12-31-1921.42%
2021-12-31-194.09%
2020-12-31-158.28%
2019-12-31-99.65%

Similar stocks

Stock NameCountryMarket CapPE Ratio
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Vaxart, Inc. (VXRT)United States$0.080B3.84
Tevogen Inc. (TVGN)United States$0.049B